chloroquine has been researched along with Immune System Diseases in 6 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Immune System Diseases: Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chloroquine and hydroxychloroquine, with an original indication to prevent or cure malaria, have been successfully used to treat several infectious (HIV, Q fever, Whipple's disease, fungal infections), rheumatological (systemic lupus erythematosus, antiphospholipid antibody syndrome, rheumatoid arthritis, Sjögren's syndrome), and other immunological diseases." | 4.98 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. ( Koudriavtseva, T; Plantone, D, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plantone, D | 1 |
| Koudriavtseva, T | 1 |
| FULD, H | 1 |
| VAN CAUWENBERGE, H | 1 |
| LECOMTE, J | 1 |
| LAPIERE, C | 1 |
| Gieldanowski, J | 1 |
| Pelczarska, A | 1 |
| Weinhold, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Proflaxis for Healthcare Professionals Using Hydroxychloroquine Plus Vitamin Combining Vitamins C, D and Zinc During COVID-19 Pandemia: An Observational Study[NCT04326725] | 80 participants (Anticipated) | Observational | 2020-03-20 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for chloroquine and Immune System Diseases
| Article | Year |
|---|---|
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antimalarials; Antineoplastic Agents; Antirheumatic | 2018 |
5 other studies available for chloroquine and Immune System Diseases
| Article | Year |
|---|---|
ACTIVITY of a new antimalarial agent, chloroquine (SN 7618).
Topics: Anaphylaxis; Antimalarials; Chloroquine; Humans; Hypersensitivity; Immune System Diseases; Malaria; | 1946 |
Chloroquine in the management of hypersensitivity states.
Topics: Chloroquine; Disease Management; Humans; Hypersensitivity; Immune System Diseases | 1958 |
[Effect of chloroquine on edema induced by ovalbumin and dextran and on Ambrose and Eds test in rat].
Topics: Animals; Chloroquine; Dextrans; Edema; Hypersensitivity; Immune System Diseases; Ovalbumin; Rats | 1958 |
Mediators and nonsteroid antiinflammatory drugs in immunologically specific and nonspecific inflammatory processes.
Topics: Adjuvants, Immunologic; Aminopyrine; Animals; Anti-Inflammatory Agents; Arthritis; Bradykinin; Chlor | 1971 |
[Subsepsis allergica as a differential diagnosis problem].
Topics: Chloroquine; Cyclophosphamide; Diagnosis, Differential; Immune System Diseases; Wissler's Syndrome | 1971 |